Cafepharma Today

February 5 2025 - GSK lifts long-term outlook on drug pipeline, buys back shares
GSK lifts long-term outlook on drug pipeline, buys back shares
Amgen's early-stage obesity asset slapped with FDA hold
Lilly’s investigational Alzheimer’s to be investigated in prevention trial
Bristol Myers Squibb, Kyowa Kirin layoffs hit 119 in New Jersey amid separate restructuring campaigns
*please scroll down for all the latest news*

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

*please scroll down for all the latest news*

Current News

submit a press release

Shareholder Class Action Filed Against Rigel Pharmaceuticals, Inc. by the Law Firm of Barroway Topaz Kessler Meltzer & Check, LLP
Yahoo
Saturday, February 21, 2009 - 12:08pm
tags:
Rigel
BVF Acquisition LLC Extends Avigen Tender Offer to March 6, 2009
Yahoo
Saturday, February 21, 2009 - 12:07pm
tags:
Avigen
Abbott Receives European Commission Clearance on Acquisition of Advanced Medical Optics
Yahoo
Saturday, February 21, 2009 - 12:04pm
tags:
Abbott Laboratories
The Skinny on Diabetes Drugs
Yahoo/Motley Fool
Saturday, February 21, 2009 - 12:02pm
tags:
diabetes
OSI Pharmaceuticals misses analyst expectations
Yahoo
Saturday, February 21, 2009 - 11:58am
tags:
OSI Pharmaceuticals
Cell Therapeutics Exercises Its Option to Sell Interest in Zevalin Joint Venture to Spectrum Pharmaceuticals for $18 Million
Yahoo
Saturday, February 21, 2009 - 11:55am
tags:
Cell Therapeutics
La Jolla 'evaluates options' after trial failure
Fierce Biotech
Friday, February 20, 2009 - 9:28am
tags:
La Jolla Pharmaceutical, Riquent
Feds Look to Extend Off-Label Marketing Streak With J&J
WSJ Online
Friday, February 20, 2009 - 9:22am
tags:
JNJ, off-label, DOJ
Wyeth Pharmaceuticals announces positive CHMP opinion for CONBRIZA for postmenopausal osteoporosis in women
Trading Markets
Friday, February 20, 2009 - 8:24am
tags:
Wyeth, CONBRIZA, osteoporosis
Crestor shows gains in reducing stroke risk
Boston Globe, MA
Friday, February 20, 2009 - 8:08am
tags:
Crestor, statins, JUPITER, stroke
Cipher wins tentative approval for pain drug
Pharmaceutical Business Review
Friday, February 20, 2009 - 8:06am
tags:
Cipher Pharmaceuticals, painkillers, Tramadol XR, chronic pain
Schering-Plough Submits Response to FDA for SAPHRIS(TM) (asenapine) in the Acute Treatment of Both Schizophrenia and Bipolar I Disorder
Yahoo
Friday, February 20, 2009 - 8:04am
tags:
Schering Plough, FDA, Saphris, bipolar disorder, schizophrenia
Vertex Aims for $320M Offering to Push Telaprevir to the Finish
BioWorld
Friday, February 20, 2009 - 8:02am
tags:
Vertex Pharmaceuticals, Telaprevir
Top U.S. lawmaker seeks more Vytorin documents
Reuters, UK
Friday, February 20, 2009 - 7:17am
tags:
Vytorin, Schering Plough, Merck
Guilty Pleas in Inquiry Into Stryker’s Marketing
NY Times, NY
Friday, February 20, 2009 - 7:15am
tags:
Stryker, off-label
Depomed initiates Phase I Parkinson's trial
Pharmaceutical Business Review
Friday, February 20, 2009 - 7:10am
tags:
Depomed, Parkinson's Disease
Lotus Pharma Looks Greatly Underpriced 3 comments
Seeking Alpha
Friday, February 20, 2009 - 7:10am
tags:
Lotus
Roche / Genentech: Lending Not So Frozen After All
Seeking Alpha
Friday, February 20, 2009 - 6:05am
tags:
Roche, Genentech, buyouts
CV Therapeutics rejects Astellas bid as loss widens
Marketwatch
Friday, February 20, 2009 - 6:03am
tags:
CV Therapeutics, Astellas, buyouts, earnings
Shire Hunts for Deals, Buys Global Rights to UCB Drug
Bloomberg
Friday, February 20, 2009 - 6:01am
tags:
Shire, UCB Pharmaceuticals, Equasym, ADD

Pages

Latest CP Wire Articles

FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies
Sapio Sciences launches new drug discovery platform
Bristol Myers Squibb Strengthens and Diversifies Oncology Portfolio With Acquisition of Mirati Therapeutics
Why Medical and Pharma Sales Reps Should Start Their Own Senior Care Business

Latest Pharmagather Articles

What's Happening Inside the NIH and NSF
In the Pipeline
Vertical Integration Redux: How Pharmaceutical Wholesalers Are Transforming the Buy-and-Bill Market (Video)
Drug Channels
Informa Connect's Access USA
Drug Channels
Fresh Asteroid, Getcher Fresh Asteroid Here
In the Pipeline
Unlocking AI’s Promise in Patient Support Programs
Drug Channels
Right There At the Electrode
In the Pipeline
Annoying Enzyme Activity
In the Pipeline
Drug Channels News Roundup, January 2025: Mark Cuban Fixes Healthcare, Payers’ G2N Bubble, Pharmacists Rejoice, 340B Shenanigans, and 46Brooklyn vs. Mushrooms
Drug Channels
Bacteria (and Their Metabolites) and Depression
In the Pipeline

Latest Jobs

Cell Therapy Navigator
Houston, Texas, 77002
Inizio Engage
Rapid Deployment Representative
Fort Worth, Texas, 76102
Inizio Engage
Rapid Deployment Representative
Charlotte, North Carolina, 28245
Inizio Engage
Oncology Key Account Manager
Newark, New Jersey, 07175
Inizio Engage
Cell Therapy Navigator
Little Rock, Arkansas, 72208
Inizio Engage
Territory Business Manager
Philadelphia, Pennsylvania, 19107
Inizio Engage
Business Development Representative
Las Vegas, Nevada, 89105
Professional Case Management
Oncology Key Account Manager
Atlanta, Georgia, 30383
Inizio Engage
Territory Manager, Surgical Pain - South Houston, TX
TX,
Avanos Medical
Neurology Account Manager- MD/DC/N VA (Remote)
Annapolis, Maryland, 21401
Jazz Pharmaceuticals
more jobs

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.

Do Not Allow Advertisers to Use My Personal information